• About Us/
  • News/
  • Investor Area/
  • Contact/
  • Home/

  • Life Sciences
  • Technology

  • Advent Venture Partners
  • Home

Advent Venture Partners is one of Europe’s most successful growth
and venture capital investors in market-leading tech and life sciences businesses


  • Algeta announces that Xofigo® (radium-223 dichloride) has been approved by the US FDA


  • First gene therapy in Western world receives positive opinion in Europe from CHMP


  • Conde Nast International leads $20m investment in farfetch


  • Cisco Announces Intent to Acquire Ubiquisys for $310m

    Acquisition Further Strengthens Cisco's Mobility Strategy to Enable More Intelligent Mobile Internet Networks for Service Providers


  • Follow Advent
  • Tech Blog
  • Twitter
  • LinkedIn

  • Legal and Regulatory Matters

©2013 Advent Venture Partners